BA
PDSB icon

BlackRock Advisors’s PDS Biotechnology PDSB Stock Holding History

BlackRock Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$124K Buy
497
+9
+2% +$2.04K ﹤0.01% 2941
2016
Q3 		$102K Buy
488
+212
+77% +$42K ﹤0.01% 3013
2016
Q2 		$56K Buy
276
+131
+90% +$23.2K ﹤0.01% 3199
2016
Q1 		$27K Hold
145
– – ﹤0.01% 3361
2015
Q4 		$36K Buy
+145
New +$46.7K ﹤0.01% 3315

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Advisors's PDSB Position: Q4 2016 in Review

BlackRock Advisors increased its PDS Biotechnology (PDSB) stake by 1.8% in Q4 2016, buying an estimated $2.04K and bringing the position to 497 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

BlackRock Advisors first reported a position in PDSB in Q4 2015 and has held it in 5 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2016.

  • BlackRock Advisors held 497 shares of PDS Biotechnology worth $124K as of Q4 2016.
  • BlackRock Advisors bought 9 PDS Biotechnology shares in Q4 2016, an estimated $2.04K.
  • PDS Biotechnology made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2941 holding.
  • BlackRock Advisors first reported a position in PDS Biotechnology in Q4 2015 and has held it in 5 quarters since.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.